Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes

被引:35
作者
West, AB
Zimprich, A
Lockhart, PJ
Farrer, M
Singleton, A
Holtom, B
Lincoln, S
Hofer, A
Hill, L
Müller-Myhsok, B
Wszolek, ZK
Hardy, J
Gasser, T
机构
[1] Klinikum Grosshadern, Neurol Forschungshaus, D-81366 Munich, Germany
[2] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA
[3] Bernhard Nocht Inst Trop Med, Hamburg, Germany
关键词
PARK3; Parkinson's disease; chromosome; 2p13; genetic and physical mapping;
D O I
10.1038/sj.ejhg.5200698
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder with clinical features of bradykinesia, rigidity, resting tremor and postural instability resulting from the deficiency of dopamine in the nigrostriatal system. Previously we mapped a susceptibility gene for an autosomal dominant form of PD to a 10.6 cM region of chromosome 2p (PARK3; OMIM 602404). A common haplotype shared by two North American kindreds (Families B and C) genealogically traced to Southern Denmark and Northern Germany suggested a founder effect. Here we report progress in the refinement of the PARK3 locus and sequence analysis of candidate genes within the region. Members of families B and C were genotyped using polymorphic markers, reducing the minimum common haplotype to eight markers spanning a physical distance of 2.5 Mb. Analysis of 14 genes within the region did not reveal any potentially pathogenic mutations segregating with the disease, implying that none of these genes are likely candidates for PARK3.
引用
收藏
页码:659 / 666
页数:8
相关论文
共 48 条
  • [1] CALNE DB, 1994, NEUROLOGY, V44, P5
  • [2] p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells
    Carpino, N
    Wisniewski, D
    Strife, A
    Marshak, D
    Kobayashi, R
    Stillman, B
    Clarkson, B
    [J]. CELL, 1997, 88 (02) : 197 - 204
  • [3] The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
    Clayton, DF
    George, JM
    [J]. TRENDS IN NEUROSCIENCES, 1998, 21 (06) : 249 - 254
  • [4] Denson M A, 1995, Parkinsonism Relat Disord, V1, P35, DOI 10.1016/1353-8020(95)00010-4
  • [5] Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON collaborative study
    deRijk, MC
    Tzourio, C
    Breteler, MMB
    Dartigues, JF
    Amaducci, L
    LopezPousa, S
    ManubensBertran, JM
    Alperovitch, A
    Rocca, WA
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (01) : 10 - 15
  • [6] Cloning, expression, and genetic mapping of Sema W, a member of the semaphorin family
    Encinas, JA
    Kikuchi, K
    Chedotal, A
    de Castro, F
    Goodman, CS
    Kimura, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) : 2491 - 2496
  • [7] Neuropathology of Parkinson's disease
    Forno, LS
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (03) : 259 - 272
  • [8] FUNCTION IN PROTEIN FOLDING OF TRIC, A CYTOSOLIC RING COMPLEX CONTAINING TCP-1 AND STRUCTURALLY RELATED SUBUNITS
    FRYDMAN, J
    NIMMESGERN, E
    ERDJUMENTBROMAGE, H
    WALL, JS
    TEMPST, P
    HARTL, FU
    [J]. EMBO JOURNAL, 1992, 11 (13) : 4767 - 4778
  • [9] A susceptibility locus for Parkinson's disease maps to chromosome 2p13
    Gasser, T
    Müller-Myhsok, B
    Wszolek, ZK
    Oehlmann, R
    Calne, DB
    Bonifati, V
    Bereznai, B
    Fabrizio, E
    Vieregge, P
    Horstmann, RD
    [J]. NATURE GENETICS, 1998, 18 (03) : 262 - 265
  • [10] GASSER T, 1999, MOVEMENT DISORD, V13, P103